Andembry
Active substance: garadacimab
garadacimab
Centralised EU authorisationActive
Marketing holder: CSL Behring GmbH
Verified 2026-10-09 · EMA
- Source: EMA
Composition
- garadacimab
Registration
- Registration number
- EMEA/H/C/006116
- Registration status
- Active
- ATC code
- B06AC07
Sources
- product · EMA · EMEA/H/C/006116 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006116 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006116 · Verified 2026-10-09